ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
25 hedge funds and large institutions have $35.3M invested in Oncternal Therapeutics, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Holders
25
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.36M | |
| 2 | +$610K | |
| 3 | +$515K | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$447K |
| 5 |
Barclays
London,
United Kingdom
|
+$81.1K |
Top Sellers
| 1 | -$66.6K | |
| 2 | -$31.9K | |
| 3 | -$13K | |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$13K |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$10.1K |